Kimball International, Inc. to Present at the Sidoti Fall 2020 Investor Conference
JASPER, Ind., Sept. 16, 2020 (GLOBE NEWSWIRE) — Kimball International, Inc. (NASDAQ: KBAL) announced its participation at the Sidoti Fall […]
Zscaler and New York University Teach Cloud Security Expertise to Cybersecurity Master’s Students
SAN JOSE, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced […]
Enlivex Announces Allowance of New Chinese Patent Covering Allocetra Immunotherapy
Nes-Ziona, Israel, Sept. 16, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd., a clinical-stage immunotherapy company, today announced that the China […]
InvisibleShield Announces Screen Protection for the New Apple Watch Series 6, Apple Watch SE, and Apple iPad Air
SALT LAKE CITY, Sept. 16, 2020 (GLOBE NEWSWIRE) — InvisibleShield®, a ZAGG Brands (NASDAQ:ZAGG) company and the leading global innovator […]
Histogen Announces $2M Grant Award from the Department of Defense for Clinical Advancement of HST-003 for Cartilage Regeneration in the Knee
Investigational New Drug (IND) Filing Expected in the Fourth Quarter of 2020SAN DIEGO, Sept. 16, 2020 (GLOBE NEWSWIRE) — Histogen […]
Volkswagen Selects Cerence to Power Voice Control in the New Fully Electric ID.3
BURLINGTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced […]
T2 Biosystems to Participate in Sepsis Alliance Summit
LEXINGTON, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]
VirTra Receives $1.5 Million Order from Federal Law Enforcement Training Centers (FLETC) for Law Enforcement Training Simulators
TEMPE, Ariz., Sept. 16, 2020 (GLOBE NEWSWIRE) — VirTra, Inc. (NASDAQ: VTSI) (“VirTra”), a global provider of training simulators for the […]
HOOKIPA Pharma’s LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article
Peer reviewed article in OncoImmunology demonstrates promising preclinical results for the novel cancer therapy targeting Human Papillomavirus 16 (HPV16) E6/E7 HPV […]
Primoris Services Corporation to Participate in Several Investor Conferences in September
DALLAS, Sept. 16, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) will be participating […]
